Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-233-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-233-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"After branded products and cigarettes, counterfeiting has spread to the medicine market, and the seven million medicinal products seized each year account for around 5% of all counterfeits. The challenge for the European authorities, judicial as well as customs, is enormous: they have to trace the sources and curb this trafficking, which is endangering millions of lives worldwide. I therefore welcome the agreement reached between Parliament and the Council to establish a common legal framework in the 27 Member States to limit the risk of falsified medicines. Of the main advances, I would mention: the principle of cascading accountability covering all actors in the chain – manufacturing authorisation holders, wholesale distributors, brokers, and so on; the compulsory use of a security device (serial number or seal) on the packaging of prescription medicines; the introduction of stricter rules on inspections carried out in cooperation with the European Medicines Agency; and the drafting of a list of entities authorised to sell products remotely.
To conclude, this is an important piece of legislation. However, more international cooperation and cyber controls are needed to eradicate falsified Viagra, slimming products, dermatological creams, and so on, which are available at the click of a mouse."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples